Novavax :
NVAX
NVAX
Stock Data
$8.88
$0.15 (1.66%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Novavax Inc is a biotechnology firm focused on enhancing global health by creating vaccines for serious infectious diseases. It uses innovative technologies like recombinant protein, nanoparticle technology, and its unique Matrix-M adjuvant to boost immune responses. The company has developed a COVID-19 vaccine, marketed under various names, for adults and adolescents. Additionally, Novavax is working on vaccines for influenza and a combination of influenza and COVID-19, as well as a malaria vaccine. Founded in 1987, Novavax is based in Gaithersburg, Maryland.
All Novavax Articles
203 Articles